-
-
-
-
-
-
-
Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share
-
-
-
-
-
-
-
Future Pak Increases Bid for Vanda Pharmaceuticals to Include CVRs in Addition to $7.25 to $7.75 Per Share in Cash
-
-
-
-
-
-
-
Future Pak Confirms Proposal to Acquire Vanda Pharmaceuticals for $7.25 to $7.75 Per Share in Cash
-
-
-
-
-
-
-
Spectrum Brands Holdings Appoints Gautam Patel and Anne S. Ward to the Board of Directors
-
-
-
-
-
-
-
Vanda Pharmaceuticals (VNDA), UCSF Enter License Agreement for CFTR Activators and Inhibitors
-
-
-
-
-
-
-
Pre-Open Stock Movers 03/05: (KYTH) (PCYC) (KR) Higher; (BRLI) (JOY) (ABBV) Lower (more...)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

